Literature DB >> 27589346

Short-Term Detraining does not Change Insulin Sensitivity and RBP4 in Rodents Previously Submitted to Aerobic Exercise.

Rafael A Marschner1, Graziela Pinto1, Júlia Borges1, Melissa Medeiros Markoski1, Beatriz D Schaan1, Alexandre Machado Lehnen1.   

Abstract

Elevated serum retinol binding protein 4 (RBP4) levels were previously described in insulin-resistance states. Exercise training can improve insulin sensitivity and RBP4, but the time-response effect of exercise detraining on RBP4 has not been studied. Thus, we examined the effects of exercise training and short-term detraining on insulin resistance, serum RBP4 levels, and GLUT4 expression in spontaneously hypertensive rats (SHR). Thirty-two male SHR, 4 months old, were submitted to 10-week treadmill training, 5 times/week or kept sedentary, followed by a 2- and 4-day detraining period. Body weight, insulin tolerance test, maximum speed in a maximal exercise test, serum RBP4 (ELISA), and epididymal fat GLUT4 expression (Western blot) were measured. Although all rats gained weight (43%, p=0.004) only the trained group showed a reduction (p<0.001) of epididymal fat weight. Detraining did not change these parameters. Exercise training increased insulin sensitivity (26%, p=0.001) and maximum exercise capacity (80%, p<0.001), benefits not lost after detraining. RBP4 levels were reduced in response to exercise training (45%, p<0.001); detraining did not change these benefits. Trained rats had increased GLUT4 expression (microsomal, ~226%; p<0.001 and plasma membrane, ~55%; p=0.011). A slight reduction in GLUT4 expression in the plasma membrane (~28%, p=0.041), but not in the microsomal fraction, was observed after 4 days of detraining. Exercise training is associated with reduced RBP4 levels, increased insulin sensitivity, and epididymal fat GLUT4 expression. Even short periods of detraining (4 days) were shown to be associated with reversal of higher plasma membrane GLUT4. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27589346     DOI: 10.1055/s-0042-115176

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  6 in total

Review 1.  Interplay of retinol binding protein 4 with obesity and associated chronic alterations (Review).

Authors:  Yaccil Adilene Flores-Cortez; Martha I Barragán-Bonilla; Juan M Mendoza-Bello; Cecilia González-Calixto; Eugenia Flores-Alfaro; Mónica Espinoza-Rojo
Journal:  Mol Med Rep       Date:  2022-06-03       Impact factor: 3.423

2.  Data Independent Acquisition Mass Spectrometry Can Identify Circulating Proteins That Predict Future Weight Loss with a Diet and Exercise Programme.

Authors:  Nagaraj Malipatil; Helene A Fachim; Kirk Siddals; Bethany Geary; Gwen Wark; Nick Porter; Simon Anderson; Rachelle Donn; Michelle Harvie; Anthony D Whetton; Martin J Gibson; Adrian Heald
Journal:  J Clin Med       Date:  2019-01-25       Impact factor: 4.241

3.  Transcriptome Analysis of the Effects of Fasting Caecotrophy on Hepatic Lipid Metabolism in New Zealand Rabbits.

Authors:  Yadong Wang; Huifen Xu; Guirong Sun; Mingming Xue; Shuaijie Sun; Tao Huang; Jianshe Zhou; Juan J Loor; Ming Li
Journal:  Animals (Basel)       Date:  2019-09-03       Impact factor: 2.752

4.  Influence of Aerobic Exercise Load Intensity on Children's Mental Health.

Authors:  Sihong Zhao
Journal:  Emerg Med Int       Date:  2022-06-11       Impact factor: 1.621

5.  The effect of moderate endurance training on gastrocnemius retinol-binding protein 4 and insulin resistance in streptozotocin-induced diabetic rats.

Authors:  Mohammad-Reza Yousefi; Hossein TaheriChadorneshin
Journal:  Interv Med Appl Sci       Date:  2018-03

Review 6.  Therapeutic Approaches to Nonalcoholic Fatty Liver Disease: Exercise Intervention and Related Mechanisms.

Authors:  Hirokazu Takahashi; Kazuhiko Kotani; Kenichi Tanaka; Yuichiro Egucih; Keizo Anzai
Journal:  Front Endocrinol (Lausanne)       Date:  2018-10-15       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.